N-[(4S)-4-[3-fluoro-4-(trifluoromethoxy)phenyl]-2,3-dihydropyrano[3,2-b]pyridin-4-yl]-N-[(2R)-2-hydroxypropyl]-6-oxo-1H-pyridine-3-carboxamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡喃吡啶类
• 英文名称: N-[(4S)-4-[3-fluoro-4-(trifluoromethoxy)phenyl]-2,3-dihydropyrano[3,2-b]pyridin-4-yl]-N-[(2R)-2-hydroxypropyl]-6-oxo-1H-pyridine-3-carboxamide
• 化学式: C₂₄H₂₁F₄N₃O₅
• 分子量: 507.4
• InChiKey: WIWAGSUAKNFZFJ-FATZIPQQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  36
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  101
• 氢给体数：
  2
• 氢受体数：
  10

文献信息

• [EN] CHROMAN DERIVATIVES AS TRPM8 INHIBITORS<br/>[FR] DÉRIVÉS DE CHROMANE EN TANT QU'INHIBITEURS DE TRPM8
  申请人：AMGEN INC

  公开号：WO2014025651A1

  公开（公告）日：2014-02-13

  Chroman compounds and derivatives of Formula (I) are useful inhibitors of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula (I) have the following structure: (I) where the definitions of the variables are provided herein.